151 related articles for article (PubMed ID: 1667818)
1. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.
Judge ME; Sheardown MJ; Jacobsen P; Honoré T
Neurosci Lett; 1991 Dec; 133(2):291-4. PubMed ID: 1667818
[TBL] [Abstract][Full Text] [Related]
2. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.
Gyertyán I; Gigler G; Simó A
Brain Res Bull; 1999 Oct; 50(3):179-86. PubMed ID: 10566979
[TBL] [Abstract][Full Text] [Related]
4. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
Hu P; Diemer NH; Bruhn T; Johansen FF
J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
[TBL] [Abstract][Full Text] [Related]
5. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
Sheardown MJ; Suzdak PD; Nordholm L
Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T
Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034
[TBL] [Abstract][Full Text] [Related]
7. The effect of an AMPA antagonist (NBQX) on postischemic neuron loss and protein synthesis in the rat brain.
Frank L; Bruhn T; Diemer NH
Exp Brain Res; 1993; 95(1):70-6. PubMed ID: 7691645
[TBL] [Abstract][Full Text] [Related]
8. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
Randle JC; Guet T; Cordi A; Lepagnol JM
Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
[TBL] [Abstract][Full Text] [Related]
9. The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells.
Balchen T; Diemer NH
Neuroreport; 1992 Sep; 3(9):785-8. PubMed ID: 1384770
[TBL] [Abstract][Full Text] [Related]
10. Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX.
Diemer NH; Jørgensen MB; Johansen FF; Sheardown M; Honoré T
Acta Neurol Scand; 1992 Jul; 86(1):45-9. PubMed ID: 1325729
[TBL] [Abstract][Full Text] [Related]
11. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
Lippert K; Welsch M; Krieglstein J
Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083
[TBL] [Abstract][Full Text] [Related]
12. Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia of gerbils.
Kuroiwa T; Bonnekoh P; Hossmann KA
Neurosci Lett; 1991 Jan; 122(2):141-4. PubMed ID: 2027511
[TBL] [Abstract][Full Text] [Related]
13. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
Moncada C; Arvin B; Le Peillet E; Meldrum BS
Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
[TBL] [Abstract][Full Text] [Related]
14. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
15. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
[TBL] [Abstract][Full Text] [Related]
16. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
Massieu L; Tapia R
Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
[TBL] [Abstract][Full Text] [Related]
17. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
Li H; Buchan AM
J Cereb Blood Flow Metab; 1993 Nov; 13(6):933-9. PubMed ID: 7691852
[TBL] [Abstract][Full Text] [Related]
18. Regional cerebral protein synthesis after transient ischemia in the rat: effect of the AMPA antagonist NBQX.
Frank L; Bruhn T; Diemer NH
Neurosci Lett; 1992 Jun; 140(1):108-12. PubMed ID: 1383888
[TBL] [Abstract][Full Text] [Related]
19. NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline) did not affect recovery of high energy phosphates and pH in early reperfusion in a rat model of transient forebrain ischemia. Or: an in vivo 31P NMR spectroscopy study.
Müller TB; Haraldseth O; Sonnewald U; Unsgård G; Petersen SB
Acta Anaesthesiol Scand; 1994 Feb; 38(2):170-4. PubMed ID: 8171953
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.
Buchan AM; Li H; Cho S; Pulsinelli WA
Neurosci Lett; 1991 Nov; 132(2):255-8. PubMed ID: 1664505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
